Annual SG&A
$135.72 M
+$52.48 M+63.06%
31 December 2023
Summary:
TG Therapeutics annual selling, general & administrative expenses is currently $135.72 million, with the most recent change of +$52.48 million (+63.06%) on 31 December 2023. During the last 3 years, it has risen by +$13.90 million (+11.41%). TGTX annual SG&A is now -10.79% below its all-time high of $152.14 million, reached on 31 December 2021.TGTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$41.97 M
+$3.18 M+8.19%
30 September 2024
Summary:
TG Therapeutics quarterly selling, general & administrative expenses is currently $41.97 million, with the most recent change of +$3.18 million (+8.19%) on 30 September 2024. Over the past year, it has increased by +$9.20 million (+28.07%). TGTX quarterly SG&A is now -4.32% below its all-time high of $43.86 million, reached on 31 December 2020.TGTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$6.15 B
-$52.58 M-0.86%
30 September 2024
Summary:
TG Therapeutics TTM selling, general & administrative expenses is currently -$6.15 billion, with the most recent change of -$52.58 million (-0.86%) on 30 September 2024. Over the past year, it has dropped by -$6.26 billion (-5490.65%). TGTX TTM SG&A is now -95968.11% below its all-time high of $146.49 million, reached on 30 September 2024.TGTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.1% | +28.1% | -5490.6% |
| 3 y3 years | +11.4% | +20.3% | -4506.3% |
| 5 y5 years | +553.8% | +1340.2% | -10000.0% |
TGTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.8% | +63.1% | at high | +232.1% | -38.6% | +0.9% |
| 5 y | 5 years | -10.8% | +553.8% | -4.3% | +1340.2% | -161.3% | +0.9% |
| alltime | all time | -10.8% | >+9999.0% | -4.3% | +4752.6% | <-9999.0% | +0.9% |
TG Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $41.97 M(+8.2%) | $146.49 M(+6.7%) |
| June 2024 | - | $38.79 M(+12.2%) | $137.29 M(+6.2%) |
| Mar 2024 | - | $34.58 M(+11.0%) | $129.22 M(+5.3%) |
| Dec 2023 | $135.72 M(+63.1%) | $31.15 M(-4.9%) | $122.70 M(+7.6%) |
| Sept 2023 | - | $32.77 M(+6.7%) | $114.06 M(+19.4%) |
| June 2023 | - | $30.71 M(+9.4%) | $95.54 M(+23.3%) |
| Mar 2023 | - | $28.07 M(+24.7%) | $77.46 M(+10.7%) |
| Dec 2022 | $83.23 M(-45.3%) | $22.50 M(+57.9%) | $70.00 M(-12.4%) |
| Sept 2022 | - | $14.25 M(+12.8%) | $79.91 M(-20.5%) |
| June 2022 | - | $12.64 M(-38.7%) | $100.56 M(-17.5%) |
| Mar 2022 | - | $20.61 M(-36.4%) | $121.94 M(-4.8%) |
| Dec 2021 | $152.14 M(+24.9%) | $32.41 M(-7.1%) | $128.09 M(-8.2%) |
| Sept 2021 | - | $34.90 M(+2.6%) | $139.54 M(-0.3%) |
| June 2021 | - | $34.02 M(+27.1%) | $139.93 M(+16.3%) |
| Mar 2021 | - | $26.76 M(-39.0%) | $120.35 M(+11.6%) |
| Dec 2020 | $121.81 M(+484.6%) | $43.86 M(+24.3%) | $107.85 M(+51.8%) |
| Sept 2020 | - | $35.30 M(+144.5%) | $71.05 M(+83.8%) |
| June 2020 | - | $14.43 M(+1.2%) | $38.66 M(+43.5%) |
| Mar 2020 | - | $14.26 M(+102.1%) | $26.95 M(+79.3%) |
| Dec 2019 | $20.84 M(+0.4%) | $7.06 M(+142.1%) | $15.03 M(+52.0%) |
| Sept 2019 | - | $2.91 M(+7.3%) | $9.88 M(+24.5%) |
| June 2019 | - | $2.72 M(+16.0%) | $7.94 M(-27.2%) |
| Mar 2019 | - | $2.34 M(+22.5%) | $10.90 M(-28.1%) |
| Dec 2018 | $20.76 M(-5.5%) | $1.91 M(+97.5%) | $15.16 M(-17.3%) |
| Sept 2018 | - | $968.00 K(-83.0%) | $18.32 M(-16.1%) |
| June 2018 | - | $5.68 M(-13.9%) | $21.83 M(+21.9%) |
| Mar 2018 | - | $6.60 M(+29.9%) | $17.91 M(+9.6%) |
| Dec 2017 | $21.98 M(+74.0%) | $5.08 M(+13.5%) | $16.33 M(+25.3%) |
| Sept 2017 | - | $4.47 M(+154.6%) | $13.04 M(+11.2%) |
| June 2017 | - | $1.76 M(-65.0%) | $11.73 M(-6.2%) |
| Mar 2017 | - | $5.02 M(+181.7%) | $12.50 M(+26.4%) |
| Dec 2016 | $12.63 M(-36.5%) | $1.78 M(-43.7%) | $9.89 M(-6.1%) |
| Sept 2016 | - | $3.17 M(+25.2%) | $10.53 M(+9.1%) |
| June 2016 | - | $2.53 M(+4.8%) | $9.65 M(-25.8%) |
| Mar 2016 | - | $2.41 M(-0.5%) | $13.01 M(-16.7%) |
| Dec 2015 | $19.89 M(-18.9%) | $2.42 M(+5.9%) | $15.63 M(-7.1%) |
| Sept 2015 | - | $2.29 M(-61.1%) | $16.82 M(-8.2%) |
| June 2015 | - | $5.89 M(+17.2%) | $18.32 M(+4.2%) |
| Mar 2015 | - | $5.02 M(+38.7%) | $17.58 M(+11.3%) |
| Dec 2014 | $24.52 M(+218.4%) | $3.62 M(-4.3%) | $15.79 M(+15.9%) |
| Sept 2014 | - | $3.79 M(-26.4%) | $13.63 M(+21.5%) |
| June 2014 | - | $5.15 M(+59.1%) | $11.22 M(+45.5%) |
| Mar 2014 | - | $3.23 M(+121.4%) | $7.71 M(+15.8%) |
| Dec 2013 | $7.70 M(+47.0%) | $1.46 M(+6.2%) | $6.66 M(-1.0%) |
| Sept 2013 | - | $1.38 M(-16.1%) | $6.72 M(+3.4%) |
| June 2013 | - | $1.64 M(-24.9%) | $6.50 M(+2.9%) |
| Mar 2013 | - | $2.18 M(+43.1%) | $6.32 M(+32.2%) |
| Dec 2012 | $5.24 M(+844.2%) | $1.53 M(+32.2%) | $4.78 M(+25.9%) |
| Sept 2012 | - | $1.15 M(-20.9%) | $3.80 M(+42.9%) |
| June 2012 | - | $1.46 M(+126.5%) | $2.66 M(+121.7%) |
| Mar 2012 | - | $644.00 K(+19.1%) | $1.20 M(-31.6%) |
| Dec 2011 | $554.70 K(-63.5%) | $540.50 K(+3706.3%) | $1.75 M(+19.3%) |
| Sept 2011 | - | $14.20 K(>+9900.0%) | $1.47 M(-15.3%) |
| June 2011 | - | $0.00(-100.0%) | $1.73 M(-21.5%) |
| Mar 2011 | - | $1.20 M(+367.7%) | $2.21 M(+45.2%) |
| Dec 2010 | $1.52 M | $256.30 K(-8.1%) | $1.52 M(-6.3%) |
| Sept 2010 | - | $278.90 K(-41.2%) | $1.62 M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $474.10 K(-7.3%) | $1.73 M(+0.2%) |
| Mar 2010 | - | $511.70 K(+42.9%) | $1.73 M(-0.0%) |
| Dec 2009 | $1.73 M(-33.7%) | $358.10 K(-8.2%) | $1.73 M(+25.2%) |
| Sept 2009 | - | $390.10 K(-17.1%) | $1.38 M(-26.3%) |
| June 2009 | - | $470.60 K(-8.2%) | $1.88 M(-18.7%) |
| Mar 2009 | - | $512.40 K(+5237.5%) | $2.31 M(-11.6%) |
| Dec 2008 | $2.61 M(-27.7%) | $9600.00(-98.9%) | $2.61 M(-21.9%) |
| Sept 2008 | - | $884.70 K(-1.9%) | $3.34 M(-0.4%) |
| June 2008 | - | $901.50 K(+10.7%) | $3.36 M(-4.3%) |
| Mar 2008 | - | $814.10 K(+9.6%) | $3.51 M(-2.8%) |
| Dec 2007 | $3.61 M(-5.7%) | $743.10 K(-17.3%) | $3.61 M(-13.5%) |
| Sept 2007 | - | $898.10 K(-14.7%) | $4.17 M(-0.6%) |
| June 2007 | - | $1.05 M(+15.1%) | $4.20 M(+6.8%) |
| Mar 2007 | - | $914.70 K(-30.0%) | $3.93 M(+2.7%) |
| Dec 2006 | $3.83 M(+67.1%) | $1.31 M(+41.4%) | $3.83 M(+16.9%) |
| Sept 2006 | - | $923.80 K(+17.5%) | $3.27 M(+15.2%) |
| June 2006 | - | $786.40 K(-3.0%) | $2.84 M(+8.9%) |
| Mar 2006 | - | $810.90 K(+7.6%) | $2.61 M(+13.9%) |
| Dec 2005 | $2.29 M(+15.1%) | $753.80 K(+53.6%) | $2.29 M(+10.0%) |
| Sept 2005 | - | $490.90 K(-11.3%) | $2.08 M(-3.3%) |
| June 2005 | - | $553.20 K(+12.2%) | $2.16 M(+4.1%) |
| Mar 2005 | - | $493.20 K(-9.7%) | $2.07 M(+4.0%) |
| Dec 2004 | $1.99 M(+11.4%) | $546.10 K(-3.0%) | $1.99 M(+0.8%) |
| Sept 2004 | - | $562.80 K(+20.3%) | $1.97 M(+8.2%) |
| June 2004 | - | $467.80 K(+13.2%) | $1.82 M(+0.2%) |
| Mar 2004 | - | $413.20 K(-22.1%) | $1.82 M(+1.9%) |
| Dec 2003 | $1.79 M(+462.7%) | $530.60 K(+28.6%) | $1.79 M(+405.4%) |
| Sept 2003 | - | $412.70 K(-11.0%) | $353.40 K(-12.4%) |
| June 2003 | - | $463.80 K(+22.4%) | $403.60 K(-4018.4%) |
| Mar 2003 | - | $378.90 K(-142.0%) | -$10.30 K(-126.7%) |
| Dec 2002 | $317.40 K(-88.9%) | -$902.00 K(-294.9%) | $38.60 K(-97.2%) |
| Sept 2002 | - | $462.90 K(+827.7%) | $1.39 M(-4.8%) |
| June 2002 | - | $49.90 K(-88.3%) | $1.46 M(-43.7%) |
| Mar 2002 | - | $427.80 K(-4.0%) | $2.58 M(-9.3%) |
| Dec 2001 | $2.85 M(-12.5%) | $445.80 K(-16.3%) | $2.85 M(+1.1%) |
| Sept 2001 | - | $532.30 K(-54.8%) | $2.82 M(-0.8%) |
| June 2001 | - | $1.18 M(+69.8%) | $2.84 M(-41.2%) |
| Mar 2001 | - | $693.90 K(+67.1%) | $4.84 M(-14.1%) |
| Dec 2000 | $3.26 M(+71.4%) | $415.20 K(-25.1%) | $5.63 M(-6.4%) |
| Sept 2000 | - | $554.20 K(-82.5%) | $6.01 M(+2.6%) |
| June 2000 | - | $3.17 M(+113.4%) | $5.86 M(+96.2%) |
| Mar 2000 | - | $1.49 M(+85.8%) | $2.99 M(+57.2%) |
| Dec 1999 | $1.90 M(-29.6%) | $800.00 K(+100.0%) | $1.90 M(+35.7%) |
| Sept 1999 | - | $400.00 K(+33.3%) | $1.40 M(-22.2%) |
| June 1999 | - | $300.00 K(-25.0%) | $1.80 M(-28.0%) |
| Mar 1999 | - | $400.00 K(+33.3%) | $2.50 M(-7.4%) |
| Dec 1998 | $2.70 M(-3.6%) | $300.00 K(-62.5%) | $2.70 M(-15.6%) |
| Sept 1998 | - | $800.00 K(-20.0%) | $3.20 M(+6.7%) |
| June 1998 | - | $1.00 M(+66.7%) | $3.00 M(+11.1%) |
| Mar 1998 | - | $600.00 K(-25.0%) | $2.70 M(-3.6%) |
| Dec 1997 | $2.80 M(+3.7%) | $800.00 K(+33.3%) | $2.80 M(+3.7%) |
| Sept 1997 | - | $600.00 K(-14.3%) | $2.70 M(-10.0%) |
| June 1997 | - | $700.00 K(0.0%) | $3.00 M(+7.1%) |
| Mar 1997 | - | $700.00 K(0.0%) | $2.80 M(+33.3%) |
| Dec 1996 | $2.70 M | $700.00 K(-22.2%) | $2.10 M(+50.0%) |
| Sept 1996 | - | $900.00 K(+80.0%) | $1.40 M(+180.0%) |
| June 1996 | - | $500.00 K | $500.00 K |
FAQ
- What is TG Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for TG Therapeutics?
- What is TG Therapeutics annual SG&A year-on-year change?
- What is TG Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for TG Therapeutics?
- What is TG Therapeutics quarterly SG&A year-on-year change?
- What is TG Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for TG Therapeutics?
- What is TG Therapeutics TTM SG&A year-on-year change?
What is TG Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of TGTX is $135.72 M
What is the all time high annual SG&A for TG Therapeutics?
TG Therapeutics all-time high annual selling, general & administrative expenses is $152.14 M
What is TG Therapeutics annual SG&A year-on-year change?
Over the past year, TGTX annual selling, general & administrative expenses has changed by +$52.48 M (+63.06%)
What is TG Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of TGTX is $41.97 M
What is the all time high quarterly SG&A for TG Therapeutics?
TG Therapeutics all-time high quarterly selling, general & administrative expenses is $43.86 M
What is TG Therapeutics quarterly SG&A year-on-year change?
Over the past year, TGTX quarterly selling, general & administrative expenses has changed by +$9.20 M (+28.07%)
What is TG Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of TGTX is -$6.15 B
What is the all time high TTM SG&A for TG Therapeutics?
TG Therapeutics all-time high TTM selling, general & administrative expenses is $146.49 M
What is TG Therapeutics TTM SG&A year-on-year change?
Over the past year, TGTX TTM selling, general & administrative expenses has changed by -$6.26 B (-5490.65%)